- Home
- ERNA vs PETZ Comparison
ERNA vs PETZ Comparison
Compare ERNA & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERNA | PETZ |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 10.9M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ERNA | PETZ |
|---|---|---|
| Price | $0.40 | $1.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 72.0K | 20.0K |
| Earning Date | 11-07-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $1,000.00 | ★ $1,046,006.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.67 | $0.65 |
| 52 Week High | $5.55 | $1.68 |
Technical Indicators
Market Signals| Indicator | ERNA | PETZ |
|---|---|---|
| Relative Strength Index (RSI) | 24.09 | 43.49 |
| Support Level | $1.12 | $1.01 |
| Resistance Level | $1.28 | $1.35 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 0.00 | 5.88 |
Price Performance
Historical ComparisonAbout ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.